| Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infection TS Churcher, T Bousema, M Walker, C Drakeley, P Schneider, ... Elife 2, e00626, 2013 | 228 | 2013 |
| Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration T Crellen, M Walker, PHL Lamberton, NB Kabatereine, EM Tukahebwa, ... Clinical Infectious Diseases 63 (9), 1151-1159, 2016 | 196 | 2016 |
| Schistosomiasis—Assessing Progress toward the 2020 and 2025 Global Goals AK Deol, FM Fleming, B Calvo-Urbano, M Walker, V Bucumi, I Gnandou, ... New England Journal of Medicine 381 (26), 2519-2528, 2019 | 176 | 2019 |
| Therapeutic efficacy and macrofilaricidal activity of doxycycline for the treatment of river blindness M Walker, S Specht, TS Churcher, A Hoerauf, MJ Taylor, MG Basáñez Clinical Infectious Diseases 60 (8), 1199-1207, 2015 | 117 | 2015 |
| Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis WA Stolk, M Walker, LE Coffeng, MG Basáñez, SJ de Vlas Parasites & vectors 8, 1-16, 2015 | 114 | 2015 |
| Toxoplasma gondii: an underestimated threat? G Milne, JP Webster, M Walker Trends in parasitology 36 (12), 959-969, 2020 | 107 | 2020 |
| Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity SR Doyle, C Bourguinat, HC Nana-Djeunga, JA Kengne-Ouafo, SDS Pion, ... PLoS neglected tropical diseases 11 (7), e0005816, 2017 | 104 | 2017 |
| Reaching the London Declaration on Neglected Tropical Diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa HC Turner, M Walker, TS Churcher, MY Osei-Atweneboana, NK Biritwum, ... Clinical Infectious Diseases 59 (7), 923-932, 2014 | 104 | 2014 |
| A research agenda for helminth diseases of humans: modelling for control and elimination MG Basanez, JS McCarthy, MD French, GJ Yang, M Walker, M Gambhir, ... PLoS neglected tropical diseases 6 (4), e1548, 2012 | 102 | 2012 |
| Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases TD Hollingsworth, ER Adams, RM Anderson, K Atkins, S Bartsch, ... Parasites & vectors 8, 1-28, 2015 | 100 | 2015 |
| The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data HC Turner, M Walker, SK Attah, NO Opoku, K Awadzi, AC Kuesel, ... Parasites & vectors 8, 1-12, 2015 | 75 | 2015 |
| Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections HC Turner, M Walker, TS Churcher, MG Basáñez Parasites & vectors 7, 1-15, 2014 | 74 | 2014 |
| Individual Predisposition, Household Clustering and Risk Factors for Human Infection with Ascaris lumbricoides: New Epidemiological Insights M Walker, A Hall, MG Basáñez PLoS neglected tropical diseases 5 (4), e1047, 2011 | 73 | 2011 |
| Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis HC Turner, TS Churcher, M Walker, MY Osei-Atweneboana, RK Prichard, ... PLoS neglected tropical diseases 7 (4), e2169, 2013 | 70 | 2013 |
| Onchocerciasis transmission in Ghana: persistence under different control strategies and the role of the simuliid vectors PHL Lamberton, RA Cheke, P Winskill, I Tirados, M Walker, ... PLoS neglected tropical diseases 9 (4), e0003688, 2015 | 69 | 2015 |
| Predicted impact of COVID-19 on neglected tropical disease programs and the opportunity for innovation J Toor, ER Adams, M Aliee, B Amoah, RM Anderson, D Ayabina, R Bailey, ... Clinical Infectious Diseases 72 (8), 1463-1466, 2021 | 67 | 2021 |
| Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness M Walker, SDS Pion, H Fang, J Gardon, J Kamgno, MG Basáñez, ... Clinical Infectious Diseases 65 (12), 2026-2034, 2017 | 67 | 2017 |
| River blindness: mathematical models for control and elimination MG Basáñez, M Walker, HC Turner, LE Coffeng, SJ de Vlas, WA Stolk Advances in parasitology 94, 247-341, 2016 | 67 | 2016 |
| River blindness: mathematical models for control and elimination MG Basáñez, M Walker, HC Turner, LE Coffeng, SJ de Vlas, WA Stolk Advances in parasitology 94, 247-341, 2016 | 67 | 2016 |
| Moxidectin: an oral treatment for human onchocerciasis P Milton, JID Hamley, M Walker, MG Basáñez Expert Review of Anti-infective Therapy 18 (11), 1067-1081, 2020 | 64 | 2020 |
Maria Gloria BasáñezProfessor of Neglected Tropical Diseases, Imperial College LondonVerified email at imperial.ac.uk
